Find Reports

Select Report Type

Reimbursement Review

Displaying 526 - 550 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Kyprolis	Carfilzomib	pcodr_profund_carfilzomib_kyprolis_mm_rel.pdf pcodr_carfilzomib_kyprolis_mm_rel_fn_rec.pdf pcodr_carfilzomib_kyprolis_mm_rel_fn_cgr.pdf pcodr_carfilzomib_kyprolis_mm_rel_fn_egr.pdf pcodr_carfilzomib_kyprolis_mm_rel_in_rec.pdf pcodr_carfilzomib_kyprolis_mm_rel_fdk_amgen.pdf pcodr_carfilzomib_kyprolis_mm_rel_pagfdk.pdf pcodr_carfilzomib_kyprolis_mm_rel_ptfdk_mmc.pdf pcodr_carfilzomib_kyprolis_mm_rel_fdk_cln.pdf pcodr_carfilzomib_kyprolis_mm_rel_coi_mmc.pdf pcodr_carfilzomib_kyprolis_mm_rel_coi_cln.pdf	Multiple Myeloma (relapsed)	Reimburse with clinical criteria and/or conditions	Complete	Sep 9, 2016	Mar 30, 2017	PC0084-000
Cortiment	Budesonide	cdr_SR0491_TBC.pdf SR0491_complete_Cortiment-Mar-24-17.pdf SR0491_Cortiment_CL_Report.pdf SR0491_Cortiment_PE_Report.pdf SR0491 Cortiment_PI_Submissions.pdf	Ulcerative Colitis	Do not reimburse	Complete	May 24, 2016	Mar 22, 2017	SR0491-000
Cinqair	Reslizumab	cdr_SR0495_Cinqair.pdf SR0495_complete_Cinqair-Mar-24-17.pdf SR0495_Cinqair_CL_Report.pdf SR0495_Cinqair_PE_Report.pdf SR0495_Cinqair_PI_Submissions.pdf	Asthma, eosinophilic	Reimburse with clinical criteria and/or conditions	Complete	Aug 4, 2016	Mar 22, 2017	SR0495-000
Actikerall	Fluorouracil and Salicylic Acid	cdr_SR0498_Actikerall.pdf SR0498_complete_Actikerall-Mar-24-17.pdf SR0498_Actikerall_CL_Report.pdf SR0498_Actikerall_PE_Report.pdf	Hyperkeratotic actinic keratosis	Reimburse with clinical criteria and/or conditions	Complete	Aug 31, 2016	Mar 22, 2017	SR0498-000
Lixiana NVAF	Edoxaban	cdr_SR0500_Lixiana_NVAF.pdf SR0500_complete_Lixiana-NVAF_Mar-23-17.pdf SR0500_Lixiana_NVAF_CL_Report.pdf SR0500_Lixiana_NVAF_PE_Report.pdf	Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism.	Reimburse with clinical criteria and/or conditions	Complete	Sep 9, 2016	Mar 21, 2017	SR0500-000
Ravicti	glycerol phenylbutyrate	cdr_SR0497_Ravicti.pdf SR0497_complete_Ravicti_Mar-23-17.pdf SR0497_Ravicti_CL_Report.pdf SR0497_Ravicti_PE_Report.pdf SR0497_Ravicti_PI_Submissions.pdf	Urea cycle disorders	Reimburse with clinical criteria and/or conditions	Complete	Aug 30, 2016	Mar 21, 2017	SR0497-000
Zykadia (Resubmission)	Ceritinib	pcodr_provfund_ceritinib_zykadia_nsclc_resub.pdf pcodr_ceritinib_zykadia_nsclc_resub_fn_rec.pdf pcodr_ceritinib_zykadia_nsclc_resub_fn_cgr.pdf pcodr_ceritinib_zykadia_nsclc_resub_fn_egr.pdf pcodr_ceritinib_zykadia_nsclc_resub_in_rec.pdf pcodr_ceritinib_zykadia_nsclc_resub_pagfdk.pdf pcodr_ceritinib_zykadia_nsclc_resub_fdk_novartis.pdf pcodr_ceritinib_zykadia_nsclc_resub_ptfdk.pdf pcodr_ceritinib_zykadia_nsclc_resub_clinfdk.pdf pcodr_ceritinib_zykadia_nsclc_resub_coi_lcc.pdf pcodr_ceritinib_zykadia_nsclc_resub_coi_clin.pdf	metastatic non-small cell lung cancer	Reimburse with clinical criteria and/or conditions	Complete	Oct 19, 2016	Mar 21, 2017	PC0094-000
Stelara/Stelara I.V.	ustekinumab	cdr_SR0501_Stelara.pdf SR0501_complete_Stelara_Mar-23-17.pdf SR0501_Stelara_CL_Report.pdf SR0501_Stelara_PE_Report.pdf SR0501_Stelara_PI_Submissions.pdf	Crohn’s disease	Reimburse with clinical criteria and/or conditions	Complete	Sep 12, 2016	Mar 21, 2017	SR0501-000
Fentora	Fentanyl buccal	cdr_SR0494_Fentora.pdf SR0494_Fentora_CL_Report.pdf SR0494_Fentora_PE_Report.pdf SR0494_complete_Fentora_Feb-23-17.pdf	Pain (breakthrough), cancer (adults)	Do not reimburse	Complete	Jul 12, 2016	Feb 21, 2017	SR0494-000
Hemangiol	Propranolol oral solution	cdr_SR0496_Hemangiol.pdf SR0496_complete_Hemangiol-Feb-23_17.pdf SR0496_Hemangiol_CL_Report.pdf SR0496_Hemangiol_PE_Report.pdf SR0496_Hemangiol_PI_Submissions.pdf	Infantile hemangioma	Reimburse with clinical criteria and/or conditions	Complete	Aug 25, 2016	Feb 21, 2017	SR0496-000
Brivlera	Brivaracetam	cdr_SR0484_Brivlera.pdf SR0484_Brivlera_CL_Report.pdf SR0484_Brivlera_PE_Report.pdf sr0484_complete_brivlera_jan-27-17.pdf	Epilepsy, partial-onset seizures	Reimburse with clinical criteria and/or conditions	Complete	Apr 19, 2016	Jan 25, 2017	SR0484-000
Darzalex	Daratumumab	pcodr_daratumumab_darzalex_mm_fn_rec.pdf pcodr_daratumumab_darzalex_mm_fn_cgr.pdf pcodr_daratumumab_darzalex_mm_fn_egr.pdf pcodr_daratumumab_darzalex_mm_in_rec.pdf pcodr_daratumumab_darzalex_mm_pagfdk.pdf pcodr_daratumumab_darzalex_mm_fdk_janssen.pdf pcodr_daratumumab_darzalex_mm_fdk_mc.pdf pcodr_daratumumab_darzalex_mm_fdk_clinician.pdf pcodr_daratumumab_darzalex_mm_coi_mc.pdf pcodr_daratumumab_darzalex_mm_coi_clinician.pdf	Multiple Myeloma	Do not reimburse	Complete	Apr 21, 2016	Dec 1, 2016	PC0079-000
Afinitor	Everolimus	pcodr_profund_everolimus_afinitor_net-gil.pdf pcodr_everolimus_afinitor_net-gil_fn_rec.pdf pcodr_everolimus_afinitor_net-gil_fn_cgr.pdf pcodr_everolimus_afinitor_net-gil_fn_egr.pdf pcodr_everolimus_afinitor_net-gil_in_rec.pdf pcodr_everolimus_afinitor_net-gil_pagfdk.pdf pcodr_everolimus_afinitor_net-gil_fdk_novartis.pdf pcodr_everolimus_afinitor_net-gil_fdk_cnets.pdf pcodr_everolimus_afinitor_net-gil_coi_cnets.pdf	Neuroendocrine tumors (NET) of Gastrointestinal or Lung origin	Reimburse with clinical criteria and/or conditions	Complete	May 30, 2016	Dec 1, 2016	PC0083-000
Quinsair	Levofloxacin	cdr_SR0493_Quinsair.pdf SR0493_complete_Quinsair_Nov-23-16.pdf SR0493_Quinsair_CL_Report.pdf SR0493_Quinsair_PE_Report.pdf SR0493_Quinsair_PI_Submissions.pdf	Cystic fibrosis with chronic pulmonary Pseudomonas aeruginosa infections	Reimburse with clinical criteria and/or conditions	Complete	May 31, 2016	Nov 21, 2016	SR0493-000
Ibrance Resubmission	Palbociclib	pcodr_profund_10093_palbociclib_ibrance_abc_resub.pdf pcodr_palbociclib_ibrance_resub_abc_fn_rec.pdf pcodr_palbociclib_ibrance_resub_abc_fn_cgr.pdf pcodr_palbociclib_ibrance_resub_abc_fn_egr.pdf pcodr_palbociclib_ibrance_resub_abc_in_rec.pdf pcodr_palbociclib_ibrance_resub_abc_pagfdk.pdf pcodr_palbociclib_ibrance_resub_abc_fdk_pfizer.pdf pcodr_palbociclib_ibrance_resub_abc_ptfdk_rethink.pdf pcodr_palbociclib_ibrance_resub_abc_ptfdk_cbcn.pdf pcodr_palbociclib_ibrance_resub_abc_coi_cbcn-rethink.pdf pcodr_palbociclib_ibrance_resub_abc_coi_clinician.pdf	Advanced breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Jun 10, 2016	Nov 21, 2016	PC0093-000
Keytruda	Pembrolizumab	pcodr_provfund_pembrolizumab_keytruda_nsclc_2lnbeyond.pdf pcodr_pembrolizumab_keytruda_nsclc_fn_rec.pdf pcodr_pembrolizumab_keytruda_nsclc_fn_cgr.pdf pcodr_pembrolizumab_keytruda_nsclc_fn_egr.pdf pcodr_pembrolizumab_keytruda_nsclc_in_rec.pdf pcodr_pembrolizumab_keytruda_nsclc_pagfdk.pdf pcodr_pembrolizumab_keytruda_nsclc_fdk_merck.pdf pcodr_pembrolizumab_keytruda_nsclc_ptfdk.pdf pcodr_pembrolizumab_keytruda_nsclc_coi_lcc.pdf pcodr_pembrolizumab_keytruda_nsclc_fdk_clinician.pdf pcodr_pembrolizumab_keytruda_nsclc_coi_clinician.pdf	Non-Small Cell Lung Cancer	Reimburse with clinical criteria and/or conditions	Complete	Apr 21, 2016	Nov 3, 2016	PC0077-000
Imbruvica	Ibrutinib	pcodr-provfund_ibrutinib_imbruvica-cll-sll-preun.pdf pcodr_ibrutinib_imbruvica_cll-sll_fn_rec.pdf pcodr_ibrutinib_imbruvica_cll-sll_fn_cgr.pdf pcodr_ibrutinib_imbruvica_cll-sll_fn_egr.pdf pcodr_ibrutinib_imbruvica_cll-sll_in_rec.pdf pcodr_ibrutinib_imbruvica_cll-sll_pagfdk.pdf pcodr_ibrutinib_imbruvica_cll-sll_fdk_janssen.pdf pcodr_ibrutinib_imbruvica_cll-sll_ptfdk_cllpag.pdf pcodr_ibrutinib_imbruvica_cll-sll_coi_cllpag.pdf pcodr_ibrutinib_imbruvica_cll-sll_ptfdk_lc.pdf pcodr_ibrutinib_imbruvica_cll-sll_coi_lc.pdf pcodr_ibrutinib_imbruvica_cll-sll_coi_clinician.pdf	Chronic Lymphocytic Leukemia (previously untreated)	Reimburse with clinical criteria and/or conditions	Complete	Apr 20, 2016	Nov 3, 2016	PC0085-000
Imbruvica	Ibrutinib	pcodr-provfund_ibrutinib_imbruvica-wm.pdf pcodr_ibrutinib_imbruvica_wm_fn_rec.pdf pcodr_ibrutinib_imbruvica_wm_fn_cgr.pdf pcodr_ibrutinib_imbruvica_wm_fn_egr.pdf pcodr_ibrutinib_imbruvica_wm_in_rec.pdf pcodr_ibrutinib_imbruvica_wm_pagfdk.pdf pcodr_ibrutinib_imbruvica_wm_fdk_janssen.pdf pcodr_ibrutinib_imbruvica_wm_ptfdk_cord.pdf pcodr_ibrutinib_imbruvica_wm_ptfdk_lc.pdf pcodr_ibrutinib_imbruvica_wm_coi_lc_cord.pdf	Waldenstrom's Macroglobulinemia	Do not reimburse	Complete	Apr 21, 2016	Nov 3, 2016	PC0082-000
Entyvio	Vedolizumab	cdr_SR0487_Entyvio.pdf SR0487_complete_Entyvio-Oct-31-16.pdf SR0487_Entyvio_CL_Report.pdf SR0487_Entyvio_PE_Report.pdf SR0487_Entyvio_PI_Submissions.pdf	Crohn's disease	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2016	Oct 31, 2016	SR0487-000
Uptravi	Selexipag	cdr_SR0482_Uptravi.pdf SR0482_complete_Uptravi-Oct-28-16.pdf SR0482_Uptravi_PI_Submissions.pdf SR0482_Uptravi_CL_Report_e.pdf SR0482_Uptravi_PE_Report.pdf	Pulmonary arterial hypertension (WHO class II and III)	Reimburse with clinical criteria and/or conditions	Complete	Mar 31, 2016	Oct 28, 2016	SR0482-000
Kuvan	Sapropterin dihydrochloride	cdr_SR0472_Kuvan.pdf SR0472_complete_Kuvan-Oct-28-16.pdf SR0472_Kuvan_PI_Submissions.pdf SR0472_Kuvan_CL_Report_e.pdf SR0472_Kuvan_PE_Report_e.pdf	Phenylketonuria (PKU)	Reimburse with clinical criteria and/or conditions	Complete	Feb 1, 2016	Oct 26, 2016	SR0472-000
Orkambi	lumacaftor/ivacaftor	cdr_SR0471_Orkambi.pdf SR0471_complete_Orkambi-Oct-28-16.pdf SR0471_Orkambi_CL_Report.pdf SR0471_Orkambi_PE_Report.pdf SR0471_Orkambi_PI_Submissions.pdf	Cystic Fibrosis, F508del CFTR mutation	Do not reimburse	Complete	Jan 28, 2016	Oct 26, 2016	SR0471-000
Epclusa	Sofosbuvir/ velpatasvir	cdr_SR0486_TBC.pdf SR0486_complete_Epclusa-Oct-28-16.pdf SR0486_Epclusa_CL_Report.pdf SR0486_Epclusa_PE_Report.pdf SR0486_Epclusa_PI_Submissions.pdf	Hepatitis C, chronic	Reimburse with clinical criteria and/or conditions	Complete	Apr 22, 2016	Oct 26, 2016	SR0486-000
Jardiance	Empagliflozin	cdr_SR0488_Jardiance.pdf SR0488_complete_Jardiance-Oct-28-16.pdf SR0488_Jardiance_CL_Report.pdf SR0488_Jardiance_PE_Report.pdf SR0488_Jardiance_PI_Submissions.pdf	Diabetes mellitus, type 2 with high cardiovascular risk	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2016	Oct 26, 2016	SR0488-000
Viacoram	perindopril arginine / amlodipine	cdr_SR0490_Viacoram.pdf SR0490_complete_Viacoram-Oct-28-16.pdf SR0490_Viacoram_CL_Report.pdf SR0490_Viacoram_PE_Report.pdf	Hypertension, essential	Reimburse with clinical criteria and/or conditions	Complete	May 2, 2016	Oct 26, 2016	SR0490-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 526 - 550 of 589

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Intraosseous Contrast Media Injection for Computed Tomography Scan or Magnetic Resonance Imaging: A Review of Clinical Effectiveness and Guidelines	RC1234 Intraosseous Devices Final.pdf	Feb 24, 2020	Summary with Critical Appraisal	Completed	RC1234-000
Artificial Intelligence for Classification of Lung Nodules: A Review of Clinical Utility, Diagnostic Accuracy, Cost-Effectiveness, and Guidelines	RC1228 AI for Lung Nodules Final.pdf	Feb 18, 2020	Summary with Critical Appraisal	Completed	RC1228-000
Clozapine Initiation for Schizophrenia: A Review of Clinical Effectiveness and Guidelines	RC1229 Clozapine Initiation Final.pdf	Feb 18, 2020	Summary with Critical Appraisal	Completed	RC1229-000
Pilocarpine for Radiotherapy-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1226 Pilocarpine for RIX Final.pdf	Feb 18, 2020	Summary with Critical Appraisal	Completed	RC1226-000
Pharmacogenomic Testing in Depression: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1232 RxGx testing depression Final.pdf	Feb 18, 2020	Summary with Critical Appraisal	Completed	RC1232-000
Major Depressive Disorder – Focused Critical Appraisal of a Network Meta-Analysis	he0022-major-depressive-disorder-critical-appraisal.pdf	Feb 18, 2020	Technology Review	Completed	HE0022-000
Physical Activity for Chronic Osteoarthritic Knee Pain: A Review of Clinical Effectiveness	RC1230 Physical Activity for KOA Final.pdf	Feb 17, 2020	Summary with Critical Appraisal	Completed	RC1230-000
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy: A Critical Appraisal of the MENTOR Study	ha0001-mentor-study-focused-crititcal-appraisal.pdf	Jan 23, 2020	Technology Review	Completed	HA0001-000
Utilization of Innovator Biologics and Biosimilars for Chronic Inflammatory Diseases in Canada: A Provincial Perspective		Jan 21, 2020			HO0007-HE0024
Internet-Based Cognitive Behavioural Therapy for Post-Traumatic Stress Disorder		Jan 20, 2020	Optimal Use	Completed	OP0537-000
csDMARDS for Rheumatoid Arthritis	op0539-cs-dmards-for-ra-fca-correction.pdf	Jan 16, 2020	Technology Review	Completed	HE0029-000
Elevated Vacuum Suspension Systems for Adults with Amputation: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1224 EVSS Final.pdf	Jan 15, 2020	Summary with Critical Appraisal	Completed	RC1224-000
Drug Therapies for the Long-Term Prophylaxis of Hereditary Angioedema Attacks	ob0007-hae-prophylaxis-redacted.pdf	Dec 19, 2019		Completed	OB0007-000
Pilocarpine for Medication-induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1225 Pilocarpine for MIX Final.pdf	Dec 11, 2019	Summary with Critical Appraisal		RC1225-000
Screening and Treatment of Obstetric Anemia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines	RC1216 - Screening and treatment of obstetric anemia Final.pdf	Dec 6, 2019	Summary with Critical Appraisal	Completed	RC1216-000
Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Biopsy for Adults with Suspected Skin Cancer: A Rapid Qualitative Review	Nov 21, 2019	Rapid Review	Completed	RC1215-000
Dosing and Timing of Immuno-Oncology Drugs	ho0008-dosing-timing-immuno-oncology-drugs.pdf	Nov 21, 2019	Technology Review	Completed	HO0008-000
Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Prostatectomy for People with Prostate Cancer: A Rapid Qualitative Review	Nov 12, 2019	Summary with Critical Appraisal	Completed	RC1209-000
Genome-Wide Sequencing: Ethical Considerations	he0020-genonme-wide-sequencing-protocol.pdf he0020-genome-wide-sequencing-ethical-considerations.pdf	Nov 12, 2019	Technology Review	Completed	HE0020-000
Healthy Aging		Oct 31, 2019			ES0342-000
Screening and Diagnostic Services for People at Risk of Breast Cancer: A Rapid Qualitative Review	Screening and Diagnostic Services for People at Risk of Breast Cancer: A Rapid …	Oct 31, 2019	Rapid Review	Completed	RC1208-000
Hemin for Injection (Panhematin): Budget Impact Analysis	ob0006_porphyria-report-redacted-final.pdf	Oct 16, 2019		Completed	OB0006-000
Second-Line Therapy for Patients with Relapsing-Remitting Multiple Sclerosis: A Review of Guidelines	RC1190 RRMS Second-line therapy Final.pdf	Sep 26, 2019	Summary with Critical Appraisal		RC1190-000
Collaboration in Health Technology Assessment in Canada: An Environmental Scan		Sep 13, 2019	Environmental Scan	Completed	ES0329-000
Hemlibra (Emicizumab): Economic Review Report	ob0005-emicizumab-eeconomic-report.pdf	Sep 11, 2019		Completed	OB0005-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 526 - 550 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Lipid Panel Screening for Adults Living With Chronic Conditions	Lipid Panel Screening for Adults Living With Chronic Conditions	Aug 10, 2023	Health Technology Review	Rapid Review	Completed	RC1497-000
Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants	Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytia…	Aug 8, 2023	Health Technology Review	Technology Review	Complete	HE0044-000
Somatropin for Turner Syndrome	Somatropin for Turner Syndrome	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1493-000
Somatropin for Growth Hormone Deficiency	Somatropin for Growth Hormone Deficiency	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1492-000
At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	Aug 4, 2023	Health Technology Review	Rapid Review	Completed	RC1495-000
ciltacabtagene autoleucel	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Aug 2, 2023	Reimbursement Review		Complete	PG0302-000
palovarotene	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Aug 1, 2023	Reimbursement Review		Complete	SR0761-000
Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Aug 1, 2023	Health Technology Review	Rapid Review	Completed	RC1496-000
Evidence Base for Virtual Primary Care	Evidence Base for Virtual Primary Care	Jul 31, 2023	Health Technology Review	Technology Review	Complete	HC0062-000
Virtual Care Rapid Scoping	Virtual Care Rapid Scoping: Main Report Virtual Care Rapid Scoping: Supporting Information Virtual Care Rapid Scoping: Summary Figures Evidence Map Virtual Care Rapid Scoping: Report Summary	Jul 31, 2023	Health Technology Review	Scoping Review	Completed	RE0041-000
ClotChip Portable Blood Clotting Sensor	ClotChip Portable Blood Clotting Sensor	Jul 31, 2023	Horizon Scan	Health Technology Update	Completed	EN0041-000
An Overview of Emerging Trends and Technologies in Ulcerative Colitis	An Overview of Emerging Trends and Technologies in Ulcerative Colitis	Jul 31, 2023	Horizon Scan	Emerging Health Technologies	Complete	EH0117-000
Individuals’ Access to Medical Imaging Results via Patient Portals	Individuals’ Access to Medical Imaging Results via Patient Portals	Jul 31, 2023	Health Technology Review	CMII Service	Completed	CM0004-000
Facial Analysis Technology for Pain Detection	Facial Analysis Technology for Pain Detection	Jul 31, 2023	Horizon Scan	Health Technology Update	Completed	EN0047-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Jul 31, 2023	Health Technology Review	Rapid Review	Completed	RC1491-000
Platelet-Rich Plasma Injections for Lower Back Pain	Platelet-Rich Plasma Injections for Lower Back Pain	Jul 31, 2023	Health Technology Review	Rapid Review	Completed	RC1485-000
An Overview of Clinical Applications of Virtual and Augmented Reality	An Overview of Clinical Applications of Virtual and Augmented Reality	Jul 31, 2023	Horizon Scan	Emerging Health Technologies	Completed	EH0111-000
CADTH Pharmaceutical Reviews Update — Issue 40		Jul 27, 2023	Reimbursement Review	Pharmaceutical Review Update
Multiple Myeloma	Final Report	Jul 27, 2023	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0031-000
Liraglutide for Pediatric Patients with Type 2 Diabetes	Liraglutide for Pediatric Patients with Type 2 Diabetes	Jul 26, 2023	Health Technology Review	Summary with Critical Appraisal	Completed	RC1494-000
Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates and Infants	Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates a…	Jul 26, 2023	Health Technology Review	Technology Review	Complete	HC0059-000
fostemsavir	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Jul 26, 2023	Reimbursement Review		Complete	SR0760-000
Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Jul 25, 2023	Health Technology Review	Summary of Abstracts	Completed	RB1673-000
selumetinib	Recommendation and Reasons Clinical, Pharmacoeconomic and Ethics combined Report Stakeholder feedback on Draft Recommendation	Jul 24, 2023	Reimbursement Review		Complete	SR0764-000
daprodustat		Jul 24, 2023	Reimbursement Review		Withdrawn	SR0762-000